Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 248

1.

Differences in proximal tubular solute clearance across common etiologies of chronic kidney disease.

Wang K, Zelnick LR, Hoofnagle AN, Chen Y, de Boer IH, Himmelfarb J, Kestenbaum B.

Nephrol Dial Transplant. 2019 Jul 25. pii: gfz144. doi: 10.1093/ndt/gfz144. [Epub ahead of print]

PMID:
31347660
2.

Effects of Calcium, Magnesium, and Potassium Concentrations on Ventricular Repolarization in Unselected Individuals.

Noordam R, Young WJ, Salman R, Kanters JK, van den Berg ME, van Heemst D, Lin HJ, Barreto SM, Biggs ML, Biino G, Catamo E, Concas MP, Ding J, Evans DS, Foco L, Grarup N, Lyytikäinen LP, Mangino M, Mei H, van der Most PJ, Müller-Nurasyid M, Nelson CP, Qian Y, Repetto L, Said MA, Shah N, Schramm K, Vidigal PG, Weiss S, Yao J, Zilhao NR, Brody JA, Braund PS, Brumat M, Campana E, Christofidou P, Caulfield MJ, De Grandi A, Dominiczak AF, Doney ASF, Eiriksdottir G, Ellervik C, Giatti L, Gögele M, Graff C, Guo X, van der Harst P, Joshi PK, Kähönen M, Kestenbaum B, Lima-Costa MF, Linneberg A, Maan AC, Meitinger T, Padmanabhan S, Pattaro C, Peters A, Petersmann A, Sever P, Sinner MF, Shen X, Stanton A, Strauch K, Soliman EZ, Tarasov KV, Taylor KD, Thio CHL, Uitterlinden AG, Vaccargiu S, Waldenberger M, Robino A, Correa A, Cucca F, Cummings SR, Dörr M, Girotto G, Gudnason V, Hansen T, Heckbert SR, Juhl CR, Kääb S, Lehtimäki T, Liu Y, Lotufo PA, Palmer CNA, Pirastu M, Pramstaller PP, Ribeiro ALP, Rotter JI, Samani NJ, Snieder H, Spector TD, Stricker BH, Verweij N, Wilson JF, Wilson JG, Jukema JW, Tinker A, Newton-Cheh CH, Sotoodehnia N, Mook-Kanamori DO, Munroe PB, Warren HR.

J Am Coll Cardiol. 2019 Jun 25;73(24):3118-3131. doi: 10.1016/j.jacc.2019.03.519.

PMID:
31221261
3.

Comparative Safety of Phosphate Binders Without Proven Efficacy-How Did We Get Here?

Kestenbaum BR, de Boer IH.

JAMA Intern Med. 2019 Jun 1;179(6):749-750. doi: 10.1001/jamainternmed.2019.0043. No abstract available.

PMID:
31058921
4.

Biomarkers of mineral metabolism and progression of aortic valve and mitral annular calcification: The Multi-Ethnic Study of Atherosclerosis.

Bortnick AE, Xu S, Kim RS, Kestenbaum B, Ix JH, Jenny NS, de Boer IH, Michos ED, Thanassoulis G, Siscovick DS, Budoff MJ, Kizer JR.

Atherosclerosis. 2019 Jun;285:79-86. doi: 10.1016/j.atherosclerosis.2019.04.215. Epub 2019 Apr 13.

PMID:
31048102
5.

Mineral Metabolism Disturbances and Arteriovenous Fistula Maturation.

Kubiak RW, Zelnick LR, Hoofnagle AN, Alpers CE, Terry CM, Shiu YT, Cheung AK, de Boer IH, Robinson-Cohen C, Allon M, Dember LM, Feldman HI, Himmelfarb J, Huber TS, Roy-Chaudhury P, Vazquez MA, Kusek JW, Beck GJ, Imrey PB, Kestenbaum B; Hemodialysis Fistula Maturation Study Group.

Eur J Vasc Endovasc Surg. 2019 May;57(5):719-728. doi: 10.1016/j.ejvs.2019.01.022. Epub 2019 Apr 15.

PMID:
31000459
6.

A Prediction Model for Severe AKI in Critically Ill Adults That Incorporates Clinical and Biomarker Data.

Bhatraju PK, Zelnick LR, Katz R, Mikacenic C, Kosamo S, Hahn WO, Dmyterko V, Kestenbaum B, Christiani DC, Liles WC, Himmelfarb J, Wurfel MM.

Clin J Am Soc Nephrol. 2019 Apr 5;14(4):506-514. doi: 10.2215/CJN.04100318. Epub 2019 Mar 27.

PMID:
30917991
7.

Urinary Concentration Ability: Time to Bring the Tubules to the Table.

Wang K, Kestenbaum B.

Am J Kidney Dis. 2019 May;73(5):583-584. doi: 10.1053/j.ajkd.2019.01.019. Epub 2019 Mar 12. No abstract available.

PMID:
30876749
8.

Commentary on Risks of Living Kidney Donation: Current State of Knowledge on Core Outcomes Important to Donors.

Kestenbaum BR, Seliger SL.

Clin J Am Soc Nephrol. 2019 Apr 5;14(4):609-610. doi: 10.2215/CJN.01650219. Epub 2019 Mar 11. No abstract available.

PMID:
30858157
9.

The association of glycated hemoglobin with mortality and ESKD among persons with diabetes and chronic kidney disease.

Limkunakul C, de Boer IH, Kestenbaum BR, Himmelfarb J, Ikizler TA, Robinson-Cohen C.

J Diabetes Complications. 2019 Apr;33(4):296-301. doi: 10.1016/j.jdiacomp.2018.12.010. Epub 2019 Jan 7.

PMID:
30795915
10.

Soluble ST2 and Galectin-3 and Progression of CKD.

Alam ML, Katz R, Bellovich KA, Bhat ZY, Brosius FC, de Boer IH, Gadegbeku CA, Gipson DS, Hawkins JJ, Himmelfarb J, Kestenbaum BR, Kretzler M, Robinson-Cohen C, Steigerwalt SP, Tuegel C, Bansal N.

Kidney Int Rep. 2018 Sep 21;4(1):103-111. doi: 10.1016/j.ekir.2018.09.013. eCollection 2019 Jan.

11.

Commentary on "Demystifying the Benefits and Harms of Anticoagulation for Atrial Fibrillation in CKD".

Kestenbaum BR, Seliger SL.

Clin J Am Soc Nephrol. 2019 Jan 7;14(1):137-138. doi: 10.2215/CJN.13431118. Epub 2018 Dec 28. No abstract available.

PMID:
30593487
12.

Low-Frequency Synonymous Coding Variation in CYP2R1 Has Large Effects on Vitamin D Levels and Risk of Multiple Sclerosis.

Manousaki D, Dudding T, Haworth S, Hsu YH, Liu CT, Medina-Gómez C, Voortman T, van der Velde N, Melhus H, Robinson-Cohen C, Cousminer DL, Nethander M, Vandenput L, Noordam R, Forgetta V, Greenwood CMT, Biggs ML, Psaty BM, Rotter JI, Zemel BS, Mitchell JA, Taylor B, Lorentzon M, Karlsson M, Jaddoe VVW, Tiemeier H, Campos-Obando N, Franco OH, Utterlinden AG, Broer L, van Schoor NM, Ham AC, Ikram MA, Karasik D, de Mutsert R, Rosendaal FR, den Heijer M, Wang TJ, Lind L, Orwoll ES, Mook-Kanamori DO, Michaëlsson K, Kestenbaum B, Ohlsson C, Mellström D, de Groot LCPGM, Grant SFA, Kiel DP, Zillikens MC, Rivadeneira F, Sawcer S, Timpson NJ, Richards JB.

Am J Hum Genet. 2018 Dec 6;103(6):1053. doi: 10.1016/j.ajhg.2018.11.010. No abstract available.

13.

Fibroblast Growth Factor-23 and Heart Failure With Reduced Versus Preserved Ejection Fraction: MESA.

Almahmoud MF, Soliman EZ, Bertoni AG, Kestenbaum B, Katz R, Lima JAC, Ouyang P, Miller PE, Michos ED, Herrington DM.

J Am Heart Assoc. 2018 Sep 18;7(18):e008334. doi: 10.1161/JAHA.117.008334.

14.

Association of Soluble TNFR-1 Concentrations with Long-Term Decline in Kidney Function: The Multi-Ethnic Study of Atherosclerosis.

Bhatraju PK, Zelnick LR, Shlipak M, Katz R, Kestenbaum B.

J Am Soc Nephrol. 2018 Nov;29(11):2713-2721. doi: 10.1681/ASN.2018070719. Epub 2018 Oct 4.

PMID:
30287518
15.

Fibroblast Growth Factor-23, Heart Failure Risk, and Renin-Angiotensin-Aldosterone-System Blockade in Hypertension: The MESA Study.

Akhabue E, Vu TT, Vaidya A, Michos ED, de Boer IH, Kestenbaum B, Allison M, Szklo M, Ouyang P, Yancy CW, Wolf M, Isakova T, Carnethon MR.

Am J Hypertens. 2019 Jan 1;32(1):18-25. doi: 10.1093/ajh/hpy142.

PMID:
30256890
16.

Genetic Variants Associated with Circulating Fibroblast Growth Factor 23.

Robinson-Cohen C, Bartz TM, Lai D, Ikizler TA, Peacock M, Imel EA, Michos ED, Foroud TM, Akesson K, Taylor KD, Malmgren L, Matsushita K, Nethander M, Eriksson J, Ohlsson C, Mellström D, Wolf M, Ljunggren O, McGuigan F, Rotter JI, Karlsson M, Econs MJ, Ix JH, Lutsey PL, Psaty BM, de Boer IH, Kestenbaum BR.

J Am Soc Nephrol. 2018 Oct;29(10):2583-2592. doi: 10.1681/ASN.2018020192. Epub 2018 Sep 14.

PMID:
30217807
17.

Chronic kidney disease attenuates the plasma metabolome response to insulin.

Roshanravan B, Zelnick LR, Djucovic D, Gu H, Alvarez JA, Ziegler TR, Gamboa JL, Utzschneider K, Kestenbaum B, Himmelfarb J, Kahn SE, Raftery D, de Boer IH.

JCI Insight. 2018 Aug 23;3(16). pii: 122219. doi: 10.1172/jci.insight.122219. eCollection 2018 Aug 23.

18.

Dietary Phosphorus and Ambulatory Blood Pressure in African Americans: The Jackson Heart Study.

Olivo RE, Hale SL, Diamantidis CJ, Bhavsar NA, Tyson CC, Tucker KL, Carithers TC, Kestenbaum B, Muntner P, Tanner RM, Booth JN 3rd, Mwasongwe SE, Pendergast J, Boulware LE, Scialla JJ.

Am J Hypertens. 2019 Jan 1;32(1):94-103. doi: 10.1093/ajh/hpy126.

PMID:
30107444
19.

Effect of Anti-Hypertensive Medication History on Arteriovenous Fistula Maturation Outcomes.

Wang K, Zelnick LR, Imrey PB, deBoer IH, Himmelfarb J, Allon MD, Cheung AK, Dember LM, Roy-Chaudhury P, Vazquez MA, Kusek JW, Feldman HI, Beck GJ, Kestenbaum B; the Hemodialysis Fistula Maturation Study Group.

Am J Nephrol. 2018;48(1):56-64. doi: 10.1159/000491828. Epub 2018 Aug 2.

20.

Alteration of HDL Protein Composition with Hemodialysis Initiation.

Wang K, Zelnick LR, Hoofnagle AN, Vaisar T, Henderson CM, Imrey PB, Robinson-Cohen C, de Boer IH, Shiu YT, Himmelfarb J, Beck GJ, Kestenbaum B; HFM Study.

Clin J Am Soc Nephrol. 2018 Aug 7;13(8):1225-1233. doi: 10.2215/CJN.11321017. Epub 2018 Jul 25.

21.

Commentary on Complications of Immunosuppressive Treatments for Glomerulonephritis.

Kestenbaum BR, Seliger SL.

Clin J Am Soc Nephrol. 2018 Aug 7;13(8):1276-1277. doi: 10.2215/CJN.07610618. Epub 2018 Jul 24. No abstract available.

22.

Serum 25-Hydroxyvitamin D Concentrations Are Associated with Computed Tomography Markers of Subclinical Interstitial Lung Disease among Community-Dwelling Adults in the Multi-Ethnic Study of Atherosclerosis (MESA).

Kim SM, Zhao D, Podolanczuk AJ, Lutsey PL, Guallar E, Kawut SM, Barr RG, de Boer IH, Kestenbaum BR, Lederer DJ, Michos ED.

J Nutr. 2018 Jul 1;148(7):1126-1134. doi: 10.1093/jn/nxy066.

23.

Heroin Use Is Associated with AA-Type Kidney Amyloidosis in the Pacific Northwest.

Sharma A, Govindan P, Toukatly M, Healy J, Henry C, Senter S, Najafian B, Kestenbaum B.

Clin J Am Soc Nephrol. 2018 Jul 6;13(7):1030-1036. doi: 10.2215/CJN.13641217. Epub 2018 Jun 15.

24.

GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD.

Tuegel C, Katz R, Alam M, Bhat Z, Bellovich K, de Boer I, Brosius F, Gadegbeku C, Gipson D, Hawkins J, Himmelfarb J, Ju W, Kestenbaum B, Kretzler M, Robinson-Cohen C, Steigerwalt S, Bansal N.

Am J Kidney Dis. 2018 Oct;72(4):519-528. doi: 10.1053/j.ajkd.2018.03.025. Epub 2018 Jun 14.

PMID:
29866459
25.

Comparative Effects of Cholecalciferol and Calcitriol on Circulating Markers of CKD Mineral Bone Disorder: A Randomized Clinical Trial.

Zelnick LR, de Boer IH, Kestenbaum BR, Chonchol M, Kendrick J.

Clin J Am Soc Nephrol. 2018 Jun 7;13(6):927-928. doi: 10.2215/CJN.00480118. Epub 2018 Mar 7. No abstract available.

26.

Proximal Tubular Secretory Clearance: A Neglected Partner of Kidney Function.

Wang K, Kestenbaum B.

Clin J Am Soc Nephrol. 2018 Aug 7;13(8):1291-1296. doi: 10.2215/CJN.12001017. Epub 2018 Feb 28. Review.

27.

Genome-wide association study in 79,366 European-ancestry individuals informs the genetic architecture of 25-hydroxyvitamin D levels.

Jiang X, O'Reilly PF, Aschard H, Hsu YH, Richards JB, Dupuis J, Ingelsson E, Karasik D, Pilz S, Berry D, Kestenbaum B, Zheng J, Luan J, Sofianopoulou E, Streeten EA, Albanes D, Lutsey PL, Yao L, Tang W, Econs MJ, Wallaschofski H, Völzke H, Zhou A, Power C, McCarthy MI, Michos ED, Boerwinkle E, Weinstein SJ, Freedman ND, Huang WY, Van Schoor NM, van der Velde N, Groot LCPGM, Enneman A, Cupples LA, Booth SL, Vasan RS, Liu CT, Zhou Y, Ripatti S, Ohlsson C, Vandenput L, Lorentzon M, Eriksson JG, Shea MK, Houston DK, Kritchevsky SB, Liu Y, Lohman KK, Ferrucci L, Peacock M, Gieger C, Beekman M, Slagboom E, Deelen J, Heemst DV, Kleber ME, März W, de Boer IH, Wood AC, Rotter JI, Rich SS, Robinson-Cohen C, den Heijer M, Jarvelin MR, Cavadino A, Joshi PK, Wilson JF, Hayward C, Lind L, Michaëlsson K, Trompet S, Zillikens MC, Uitterlinden AG, Rivadeneira F, Broer L, Zgaga L, Campbell H, Theodoratou E, Farrington SM, Timofeeva M, Dunlop MG, Valdes AM, Tikkanen E, Lehtimäki T, Lyytikäinen LP, Kähönen M, Raitakari OT, Mikkilä V, Ikram MA, Sattar N, Jukema JW, Wareham NJ, Langenberg C, Forouhi NG, Gundersen TE, Khaw KT, Butterworth AS, Danesh J, Spector T, Wang TJ, Hyppönen E, Kraft P, Kiel DP.

Nat Commun. 2018 Jan 17;9(1):260. doi: 10.1038/s41467-017-02662-2.

28.

Transethnic Evaluation Identifies Low-Frequency Loci Associated With 25-Hydroxyvitamin D Concentrations.

Hong J, Hatchell KE, Bradfield JP, Bjonnes A, Chesi A, Lai CQ, Langefeld CD, Lu L, Lu Y, Lutsey PL, Musani SK, Nalls MA, Robinson-Cohen C, Roizen JD, Saxena R, Tucker KL, Ziegler JT, Arking DE, Bis JC, Boerwinkle E, Bottinger EP, Bowden DW, Gilsanz V, Houston DK, Kalkwarf HJ, Kelly A, Lappe JM, Liu Y, Michos ED, Oberfield SE, Palmer ND, Rotter JI, Sapkota B, Shepherd JA, Wilson JG, Basu S, de Boer IH, Divers J, Freedman BI, Grant SFA, Hakanarson H, Harris TB, Kestenbaum BR, Kritchevsky SB, Loos RJF, Norris JM, Norwood AF, Ordovas JM, Pankow JS, Psaty BM, Sanghera DK, Wagenknecht LE, Zemel BS, Meigs J, Dupuis J, Florez JC, Wang T, Liu CT, Engelman CD, Billings LK.

J Clin Endocrinol Metab. 2018 Apr 1;103(4):1380-1392. doi: 10.1210/jc.2017-01802.

29.

Commentary on Treatment of Severe Hyponatremia.

Seliger S, Kestenbaum B.

Clin J Am Soc Nephrol. 2018 Apr 6;13(4):650-651. doi: 10.2215/CJN.13381217. Epub 2018 Jan 2. No abstract available.

30.

Commentary on Lessons from CKD-Related Genetic Association Studies-Moving Forward.

Kestenbaum B, Seliger SL.

Clin J Am Soc Nephrol. 2018 Jan 6;13(1):153-154. doi: 10.2215/CJN.12421117. Epub 2017 Dec 14. No abstract available.

31.

Stuck in a Bind With Phosphate Binders.

Kestenbaum B, Psaty BM.

Am J Kidney Dis. 2018 Feb;71(2):254-256. doi: 10.1053/j.ajkd.2017.08.029. Epub 2017 Dec 7. No abstract available.

PMID:
29224957
32.

The 24,25 to 25-hydroxyvitamin D ratio and fracture risk in older adults: The cardiovascular health study.

Ginsberg C, Katz R, de Boer IH, Kestenbaum BR, Chonchol M, Shlipak MG, Sarnak MJ, Hoofnagle AN, Rifkin DE, Garimella PS, Ix JH.

Bone. 2018 Feb;107:124-130. doi: 10.1016/j.bone.2017.11.011. Epub 2017 Nov 16.

33.

Metabolomics and Gene Expression Analysis Reveal Down-regulation of the Citric Acid (TCA) Cycle in Non-diabetic CKD Patients.

Hallan S, Afkarian M, Zelnick LR, Kestenbaum B, Sharma S, Saito R, Darshi M, Barding G, Raftery D, Ju W, Kretzler M, Sharma K, de Boer IH.

EBioMedicine. 2017 Dec;26:68-77. doi: 10.1016/j.ebiom.2017.10.027. Epub 2017 Oct 31.

34.

Diabetes and CKD in the United States Population, 2009-2014.

Zelnick LR, Weiss NS, Kestenbaum BR, Robinson-Cohen C, Heagerty PJ, Tuttle K, Hall YN, Hirsch IB, de Boer IH.

Clin J Am Soc Nephrol. 2017 Dec 7;12(12):1984-1990. doi: 10.2215/CJN.03700417. Epub 2017 Oct 20.

35.

The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension: A Cohort Study.

Brown JM, Robinson-Cohen C, Luque-Fernandez MA, Allison MA, Baudrand R, Ix JH, Kestenbaum B, de Boer IH, Vaidya A.

Ann Intern Med. 2017 Nov 7;167(9):630-641. doi: 10.7326/M17-0882. Epub 2017 Oct 10.

36.

Work Disability Among Native-born and Foreign-born Americans: On Origins, Health, and Social Safety Nets.

Engelman M, Kestenbaum BM, Zuelsdorff ML, Mehta NK, Lauderdale DS.

Demography. 2017 Dec;54(6):2273-2300. doi: 10.1007/s13524-017-0617-8.

37.

Commentary on "Effectiveness of Treatment Modalities on Kidney Stone Recurrence".

Seliger SL, Kestenbaum BR.

Clin J Am Soc Nephrol. 2017 Oct 6;12(10):1709-1710. doi: 10.2215/CJN.07780717. Epub 2017 Aug 22. No abstract available.

38.

Association of cardiovascular disease risk factors with coronary artery calcium volume versus density.

Thomas IC, Shiau B, Denenberg JO, McClelland RL, Greenland P, de Boer IH, Kestenbaum BR, Lin GM, Daniels M, Forbang NI, Rifkin DE, Hughes-Austin J, Allison MA, Jeffrey Carr J, Ix JH, Criqui MH.

Heart. 2018 Jan;104(2):135-143. doi: 10.1136/heartjnl-2017-311536. Epub 2017 Aug 16.

39.

eGFR and Albuminuria in Relation to Risk of Incident Atrial Fibrillation: A Meta-Analysis of the Jackson Heart Study, the Multi-Ethnic Study of Atherosclerosis, and the Cardiovascular Health Study.

Bansal N, Zelnick LR, Alonso A, Benjamin EJ, de Boer IH, Deo R, Katz R, Kestenbaum B, Mathew J, Robinson-Cohen C, Sarnak MJ, Shlipak MG, Sotoodehnia N, Young B, Heckbert SR.

Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1386-1398. doi: 10.2215/CJN.01860217. Epub 2017 Aug 10.

40.

Effects of Vitamin D2 Supplementation on Vitamin D3 Metabolism in Health and CKD.

Batacchi Z, Robinson-Cohen C, Hoofnagle AN, Isakova T, Kestenbaum B, Martin KJ, Wolf MS, de Boer IH.

Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1498-1506. doi: 10.2215/CJN.00530117. Epub 2017 Aug 2.

41.

Low-Frequency Synonymous Coding Variation in CYP2R1 Has Large Effects on Vitamin D Levels and Risk of Multiple Sclerosis.

Manousaki D, Dudding T, Haworth S, Hsu YH, Liu CT, Medina-Gómez C, Voortman T, van der Velde N, Melhus H, Robinson-Cohen C, Cousminer DL, Nethander M, Vandenput L, Noordam R, Forgetta V, Greenwood CMT, Biggs ML, Psaty BM, Rotter JI, Zemel BS, Mitchell JA, Taylor B, Lorentzon M, Karlsson M, Jaddoe VVW, Tiemeier H, Campos-Obando N, Franco OH, Utterlinden AG, Broer L, van Schoor NM, Ham AC, Ikram MA, Karasik D, de Mutsert R, Rosendaal FR, den Heijer M, Wang TJ, Lind L, Orwoll ES, Mook-Kanamori DO, Michaëlsson K, Kestenbaum B, Ohlsson C, Mellström D, de Groot LCPGM, Grant SFA, Kiel DP, Zillikens MC, Rivadeneira F, Sawcer S, Timpson NJ, Richards JB.

Am J Hum Genet. 2017 Aug 3;101(2):227-238. doi: 10.1016/j.ajhg.2017.06.014. Epub 2017 Jul 27. Erratum in: Am J Hum Genet. 2018 Dec 6;103(6):1053.

42.

Kidney function is associated with an altered protein composition of high-density lipoprotein.

Rubinow KB, Henderson CM, Robinson-Cohen C, Himmelfarb J, de Boer IH, Vaisar T, Kestenbaum B, Hoofnagle AN.

Kidney Int. 2017 Dec;92(6):1526-1535. doi: 10.1016/j.kint.2017.05.020. Epub 2017 Jul 26.

43.

Does Secretory Clearance Follow Glomerular Filtration Rate in Chronic Kidney Diseases? Reconsidering the Intact Nephron Hypothesis.

Chapron A, Shen DD, Kestenbaum BR, Robinson-Cohen C, Himmelfarb J, Yeung CK.

Clin Transl Sci. 2017 Sep;10(5):395-403. doi: 10.1111/cts.12481. Epub 2017 Jul 4.

44.

Relation of Serum Vitamin D to Risk of Mitral Annular and Aortic Valve Calcium (from the Multi-Ethnic Study of Atherosclerosis).

Tibuakuu M, Zhao D, de Boer IH, Guallar E, Bortnick AE, Lutsey PL, Budoff MJ, Kizer JR, Kestenbaum BR, Michos ED.

Am J Cardiol. 2017 Aug 1;120(3):473-478. doi: 10.1016/j.amjcard.2017.05.004. Epub 2017 May 11.

45.

Associations of Vitamin D-Binding Globulin and Bioavailable Vitamin D Concentrations With Coronary Heart Disease Events: The Multi-Ethnic Study of Atherosclerosis (MESA).

Robinson-Cohen C, Zelnick LR, Hoofnagle AN, Lutsey PL, Burke G, Michos ED, Shea SJC, Tracy R, Siscovick DS, Psaty B, Kestenbaum B, de Boer IH.

J Clin Endocrinol Metab. 2017 Aug 1;102(8):3075-3084. doi: 10.1210/jc.2017-00296.

46.

Serum Phosphate and Retinal Microvascular Changes: The Multi-Ethnic Study of Atherosclerosis and the Beaver Dam Eye Study.

Mehta R, Hodakowski A, Cai X, Lee KE, Kestenbaum BR, de Boer IH, Fawzi A, Wong TY, Ix J, Klein B, Klein R, Isakova T.

Ophthalmic Epidemiol. 2017 Dec;24(6):371-380. doi: 10.1080/09286586.2017.1304562. Epub 2017 Apr 12.

47.

NFAT5 and SLC4A10 Loci Associate with Plasma Osmolality.

Böger CA, Gorski M, McMahon GM, Xu H, Chang YC, van der Most PJ, Navis G, Nolte IM, de Borst MH, Zhang W, Lehne B, Loh M, Tan ST, Boerwinkle E, Grams ME, Sekula P, Li M, Wilmot B, Moon JG, Scheet P, Cucca F, Xiao X, Lyytikäinen LP, Delgado G, Grammer TB, Kleber ME, Sedaghat S, Rivadeneira F, Corre T, Kutalik Z, Bergmann S, Nielson CM, Srikanth P, Teumer A, Müller-Nurasyid M, Brockhaus AC, Pfeufer A, Rathmann W, Peters A, Matsumoto M, de Andrade M, Atkinson EJ, Robinson-Cohen C, de Boer IH, Hwang SJ, Heid IM, Gögele M, Concas MP, Tanaka T, Bandinelli S, Nalls MA, Singleton A, Tajuddin SM, Adeyemo A, Zhou J, Doumatey A, McWeeney S, Murabito J, Franceschini N, Flessner M, Shlipak M, Wilson JG, Chen G, Rotimi CN, Zonderman AB, Evans MK, Ferrucci L, Devuyst O, Pirastu M, Shuldiner A, Hicks AA, Pramstaller PP, Kestenbaum B, Kardia SLR, Turner ST, Study LC, Briske TE, Gieger C, Strauch K, Meisinger C, Meitinger T, Völker U, Nauck M, Völzke H, Vollenweider P, Bochud M, Waeber G, Kähönen M, Lehtimäki T, März W, Dehghan A, Franco OH, Uitterlinden AG, Hofman A, Taylor HA, Chambers JC, Kooner JS, Fox CS, Hitzemann R, Orwoll ES, Pattaro C, Schlessinger D, Köttgen A, Snieder H, Parsa A, Cohen DM.

J Am Soc Nephrol. 2017 Aug;28(8):2311-2321. doi: 10.1681/ASN.2016080892. Epub 2017 Mar 30.

48.

Association of Vitamin D Metabolites With Arterial Function in the Hemodialysis Fistula Maturation Study.

van Ballegooijen AJ, Zelnick L, Hoofnagle AN, Hamburg NM, Robinson-Cohen C, Roy-Chaudhury P, Cheung AK, Shiu YT, de Boer IH, Himmelfarb J, Beck G, Imrey PB, Kusek JW, Kestenbaum B; Hemodialysis Fistula Maturation (HFM) Study Group.

Am J Kidney Dis. 2017 Jun;69(6):805-814. doi: 10.1053/j.ajkd.2017.01.049. Epub 2017 Mar 27.

49.

Fibroblast Growth Factor 23, Mineral Metabolism, and Adiposity in Normal Kidney Function.

Zaheer S, de Boer IH, Allison M, Brown JM, Psaty BM, Robinson-Cohen C, Michos ED, Ix JH, Kestenbaum B, Siscovick D, Vaidya A.

J Clin Endocrinol Metab. 2017 Apr 1;102(4):1387-1395. doi: 10.1210/jc.2016-3563.

50.

Bone Mineral Density and Risk of Heart Failure in Older Adults: The Cardiovascular Health Study.

Fohtung RB, Brown DL, Koh WJ, Bartz TM, Carbone LD, Civitelli R, Stein PK, Chaves PH, Kestenbaum BR, Kizer JR.

J Am Heart Assoc. 2017 Mar 13;6(3). pii: e004344. doi: 10.1161/JAHA.116.004344.

Supplemental Content

Loading ...
Support Center